Five branded products, two of them oral
Alongside its two compounded lanes it lists a Wegovy injection, a Wegovy pill, a Zepbound pen, a Zepbound vial and Foundayo, the orforglipron tablet. Two of those are taken by mouth. Eight rows here price a brand-name orforglipron pill and a handful price the branded semaglutide tablet, so the branded oral lane is small but not empty.
It also names the fulfilment channel for the branded lane, stating that medication ships through the manufacturer's own direct-pay pharmacy. That is more than most sellers say about where a branded prescription actually goes.
The compounded tiles name their active ingredient in capitals, so a reader does not have to guess which drug a personalised GLP-1 contains.
The figure under the branded products is a consultation fee
Every one of the five branded listings carries the same figure. The asterisk beneath it says the money covers the provider consultation and follow-ups only, and that the medication is charged separately once the consult is approved.
That charge is never published. So the site advertises a number against Wegovy, against Zepbound and against Foundayo, and none of those numbers is the price of the drug.
We store all three as rows that explicitly do not cover medication, which is what the field exists for. A reader who reads the advertised figure as the cost of branded Wegovy is wrong by roughly an order of magnitude, and the page makes that easy to do.
The compounded lane is priced properly
Its compounded semaglutide is flat across every dose in the seller's own words, and its dual-incretin lane starts at a stated figure. Both include the drug, and neither is hedged with an insurance condition.
That makes the contrast on this site sharp: the compounded prices mean what they appear to mean, and the branded ones do not.
Nobody's name is on it
We searched five pages, about a hundred and ten thousand characters, for every corporate suffix in common use, and proved the matcher against a control string in the same run so that a zero would mean something. It found a drug manufacturer named in a trademark disclaimer and an arbitration administrator. It found no operating company.
The FDA's own warning letter names the firm as Kin Meds with no corporate form either. One page we would expect to carry the name, the privacy policy, refuses us with a 403, so the name may be there and unreadable to us. We record that rather than claiming the site has none.
No compounding pharmacy is named for the compounded lane, no prescribing clinician is named, and no list of served states appears.
It carries an FDA warning letter issued in February 2026 over false and misleading claims and misbranding. That is a disclosure and it does not move this seller's position here.
Kin Meds's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $199/moper month, all doses — the seller writes "All doses just $199/month. No insurance required, no office visit" and marks the product "*CONTAINS SEMAGLUTIDE" | September 2026source |
| Tirzepatide (compounded) | $249/moper month, from — "Doses Start at $249/month", on a product marked "*CONTAINS TIRZEPATIDE" | September 2026source |
| Semaglutide (brand) | $149/mo⛔ THIS BUYS NO MEDICINE. The branded page prints "Starting at $149" beside each product and footnotes it, verbatim: "$149 for the provider consultation and follow ups only. Price of the medication(s) are charged upon consult approval. Your Medication will be shipped through NovoCare." The drug price is not published on the pages we read | September 2026source |
| Tirzepatide (brand) | $149/mo⛔ THIS BUYS NO MEDICINE — the same consultation-only footnote governs the two Zepbound listings; the drug price is not published on the pages we read | September 2026source |
| Orforglipron (brand) | $149/mo⛔ THIS BUYS NO MEDICINE — the same consultation-only footnote governs the Foundayo listing; the drug price is not published on the pages we read | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 264 providers reviewed here are paid partners today; the other 260 are not. See how this works.
See Kin Meds's current price →Good fit if
- Readers who want a branded GLP-1 they can swallow.
- Buyers who want the molecule named on the tile rather than in the small print.
- People shopping the compounded lane, where the published figure does cover the drug.
Look elsewhere if
- Anyone who needs to know what a branded prescription will actually cost before starting.
- Buyers who want a named company standing behind the sale.
- Readers who need the compounding pharmacy named.
- Anyone who needs their state confirmed before an intake.
How this review was verified
- Read the homepage, the GLP-1 page, the branded-medications page, the treatments index and the terms of use on 7 September 2026, comparing requested to effective URLs, with a nonsense path on the same host in the same run — it returned a 404 carrying a body larger than several real pages, so the status code decided.
- Quoted the consultation-only footnote in full and recorded the branded figures as rows that do not cover medication, rather than as drug prices.
- Censused all five pages for a corporate name with a matcher proved against a control string in the same run, and recorded the two names it did find and why neither is the seller.
- Recorded the 403 on the privacy policy as unverified rather than as evidence of absence.
- Screened the live FDA warning-letter datatable with a positive control returning exactly one row and a nonsense control returning none, then fetched the letter and confirmed its body names this seller's domain.